Published in Br J Dermatol on April 12, 2010
The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med (2015) 0.81
T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin. Dermatopathology (Basel) (2016) 0.75
Cardiovascular Disease Risk Among Young Urban Women. J Womens Health (Larchmt) (2016) 0.75
T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. J Pathol Clin Res (2016) 0.75
Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol (1988) 3.88
Is pretreatment with Beta-blockers beneficial in patients with acute coronary syndrome? Cardiology (2009) 2.08
The catalytic subunits of protein phosphatase-1 and protein phosphatase 2A are distinct gene products. Eur J Biochem (1984) 1.76
Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med (1986) 1.60
Characterisation of a reconstituted Mg-ATP-dependent protein phosphatase. Eur J Biochem (1983) 1.58
Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol (2001) 1.54
Reconstitution of a Mg-ATP-dependent protein phosphatase and its activation through a phosphorylation mechanism. FEBS Lett (1982) 1.51
Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model. Heart (2008) 1.45
Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clin Exp Immunol (1984) 1.45
Calcium binding to fluorescent calcium indicators: calcium green, calcium orange and calcium crimson. Biochem Biophys Res Commun (1991) 1.44
Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J (1996) 1.42
The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes. Cardiology (2007) 1.40
Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant (1989) 1.39
Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol (2001) 1.38
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol (1999) 1.36
Clinicopathologic correlations in leukemia cutis. J Am Acad Dermatol (1984) 1.36
Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med (1984) 1.34
Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest (1994) 1.33
Trigeminal cardiac reflex: new thinking model about the definition based on a literature review. Medicine (Baltimore) (2015) 1.30
Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci U S A (1993) 1.30
Kinetics of calcium binding to fluo-3 determined by stopped-flow fluorescence. Biochem Biophys Res Commun (1989) 1.30
A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet (1995) 1.29
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta (1996) 1.29
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet (2004) 1.19
Different translocation of three distinct PKC isoforms with tumor-promoting phorbol ester in human platelets. Biochem Biophys Res Commun (1991) 1.17
Activation of human peripheral monocytes by angiotensin II. FEBS Lett (1994) 1.16
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A (1996) 1.12
Calcium and magnesium binding to rat parvalbumin. Eur J Biochem (1994) 1.09
Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul (1990) 1.08
The vasodilator potency of atrial natriuretic peptide in man. Circulation (1987) 1.07
Cutaneous myiasis due to Dermatobia hominis. Dermatology (2004) 1.06
Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine. Biochem Biophys Res Commun (1984) 1.06
Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension (1989) 1.05
Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. J Am Coll Cardiol (1986) 1.05
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart. Biochemistry (1992) 1.01
Histamine-induced phosphoinositide metabolism in cultured human umbilical vein endothelial cells. Association with thromboxane and prostacyclin release. Biochem Biophys Res Commun (1987) 1.00
Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol (1998) 0.99
Pancreatic panniculitis in a patient with an acinar cell cystadenocarcinoma of the pancreas. Dermatology (2004) 0.99
Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett (1986) 0.97
Endothelin messenger RNA and receptors are differentially expressed in cultured human breast epithelial and stromal cells. J Clin Invest (1990) 0.95
Biphasic Ca2+ response of adenylate cyclase. The role of calmodulin in its activation by Ca2+ ions. Eur J Biochem (1986) 0.95
Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients. Am J Med (1984) 0.94
Factors influencing the hypotensive effects of calcium antagonists. Hypertension (1983) 0.92
Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology (2005) 0.92
Amino acid sequence at the site on protein phosphatase inhibitor-2, phosphorylated by glycogen synthase kinase-3. Biochim Biophys Acta (1984) 0.92
Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem Biophys Res Commun (1996) 0.91
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol (1987) 0.91
Myocardial tissue characterization in heart failure by real-time integrated backscatter. Eur J Ultrasound (1999) 0.90
Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.90
LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin. Mol Cell Biochem (2005) 0.90
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
S100A1 deficiency results in prolonged ventricular repolarization in response to sympathetic activation. Gen Physiol Biophys (2008) 0.89
Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism. Am J Med Genet (1999) 0.88
Functional aspects of vascular tenascin-C expression. J Vasc Res (1995) 0.88
Extracellular matrix: differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats. J Cell Physiol (1989) 0.88
The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. Biochem Biophys Res Commun (2000) 0.88
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists. Am J Cardiol (1985) 0.87
Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol (1990) 0.87
Calcium transients in human platelets monitored by aequorin, fura-2 and quin-2: effects of protein kinase C activation and inhibition. Biochem Biophys Res Commun (1987) 0.86
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. Biochem Biophys Res Commun (1991) 0.86
Calcium antagonists and the second drug for hypertensive therapy. Am J Med (1986) 0.86
Vascular smooth muscle cell calcium fluxes. Regulation by angiotensin II and lipoproteins. Hypertension (1993) 0.86
Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensive subjects. Hypertension (1984) 0.86
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Human cardiac plasma concentrations of atrial natriuretic peptide quantified by radioreceptor assay. Biochem Biophys Res Commun (1985) 0.86
Zosteriform metastases in melanoma. J Am Acad Dermatol (1995) 0.86
Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases. Arch Dermatol (1983) 0.85
T-cell subsets in cutaneous sarcoidosis. Arch Dermatol (1983) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
(-)-Adrenaline-induced, calcium-dependent phosphorylation of proteins in human platelets. J Clin Invest (1985) 0.84
Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin. FEBS Lett (1998) 0.84
Effect of tumour-promoting phorbol ester, thrombin and vasopressin on translocation of three distinct protein kinase C isoforms in human platelets and regulation by calcium. Biochem J (1992) 0.84
Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. J Cardiovasc Pharmacol (1990) 0.84
Increased cardiac myosin ATPase activity as a biochemical adaptation to running training: enhanced response to catecholamines and a role for myosin phosphorylation. J Mol Cell Cardiol (1981) 0.84
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors. Br J Pharmacol (1985) 0.84
Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. Hypertension (1983) 0.83
Excitatory and inhibitory modulation of intracellular free calcium in human platelets by hormones and drugs. Eur J Pharmacol (1983) 0.83
Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb (1993) 0.83
Dephosphorylation of myofibrillar proteins in actomyosin preparations and in isolated perfused rat hearts after beta-agonist withdrawal. J Mol Cell Cardiol (1982) 0.83
Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function. Eur J Biochem (1986) 0.83
Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol (1996) 0.82
Differential stimulation of growth related metabolism in cultured smooth muscle cells from SHR and WKY rats by combinations of EGF and LDL. Biochem Biophys Res Commun (1989) 0.82
Femoral neck fatigue fracture. Arch Orthop Trauma Surg (1980) 0.82
Translocation of protein kinase C is not required to inhibit the antigen-induced increase of cytosolic calcium in a mast cell line. Biochem Biophys Res Commun (1987) 0.82
Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells. Biochem J (1987) 0.82
Antihypertensive therapy with the long-acting calcium antagonist nitrendipine. J Cardiovasc Pharmacol (1984) 0.82
Isolated lichen planus of the lip. Br J Dermatol (1995) 0.81
Use of calcium antagonists as monotherapy in the management of hypertension. Am J Med (1984) 0.81
Measurement of receptor induced changes in intracellular free calcium in human platelets. J Recept Res (1984) 0.81
Identification of T-cell subpopulations in granuloma annulare. Arch Dermatol (1983) 0.81